Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer.

When children and adolescents go through cancer treatment, they often face serious side effects that affect their ability to move, play, and attend school. Physiotherapy might help with some of these problems, but researchers wanted to know whether specific physio interventions aimed at symptom relief and managing treatment side effects actually work. A team led by Ospina reviewed all high-quality studies comparing physio treatment to standard care or no treatment in young people aged 0 to 19 years during or after cancer therapy.

After searching extensively through medical databases and contacting researchers, they found no rigorous trials that met their criteria. The findings point to a significant gap in the evidence base: we simply don't have enough solid research yet to say whether these targeted physio approaches are effective.

Cancer treatment in children and young people can cause lasting difficulties with movement, strength, balance, nerve pain, and tiredness. Physio may help manage some of these side effects and help young people get back to activities they enjoy, like playing or going to school.

Right now, though, there hasn't been enough high-quality research to know for sure which physio approaches work best or how much they help. This doesn't mean physio isn't useful.

It means researchers need to do larger, better-designed studies to find out what actually makes a difference for young people with cancer. The good news is that the research community recognizes this gap and is working toward filling it.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

Current evidence is inadequate to support specific recommendations about physio interventions targeted at symptom relief and compensation of cancer-related side effects in young people. Although the clinical need is clear, the absence of eligible randomised or controlled trials in this population reflects both the rarity of pediatric cancer and the practical challenges of conducting rigorous research in this setting.

The gap is particularly noticeable given that children undergoing cancer treatment experience well-documented impairments including peripheral neuropathy, gait deficits, weakness, and fatigue that seem amenable to physio management. The review authors have outlined concrete research priorities: future trials need consistent inclusion criteria, standardized intervention protocols, long-term follow-up, and measurement of outcomes specific to cancer-related impairments.

Until such evidence emerges, clinical practice in this area remains guided by expert consensus and individual case reasoning rather than trial data.